31
Participants
Start Date
February 28, 2013
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Intravenous administration of ferric carboxymaltose
Intravenous administration of ferric carboxymaltose 15mg/kg up to a maximum dose of 1000mg
Subacute hypoxic exposures
Exposure to six hours of isocapnic hypoxia with end-tidal partial pressure of oxygen clamped at 55 Torr, with and without prior iron infusion
University of Oxford Department of Physiology, Anatomy and Genetics, Oxford
National Institute for Health Research, United Kingdom
OTHER_GOV
British Heart Foundation
OTHER
University of Oxford
OTHER